Drugmakers take steps to fend off future attacks
Worried about drawing Trump's ire, they aim to limit price increases and lobbying groups have pushed ahead with major campaigns intended to win back the narrative
Add BT as a preferred source
DeeperDive is a beta AI feature. Refer to full articles for the facts.
New York
IF the nation's pharmaceutical executives thought Donald Trump would grant them a reprieve from scrutiny over high drug prices, he made them reconsider that idea in the last few days.
"I'm going to bring down drug prices," he told Time magazine in an interview published on Wednesday. "I don't like what's happened with drug prices."
Share with us your feedback on BT's products and services
TRENDING NOW
Shelving S$5 billion office redevelopment plan proved ‘wise’ as geopolitical risks mount: OCBC chairman
China pips the US if Asean is forced to choose, but analysts warn against reading it like a sports result
Beijing’s calculated silence on the Iran war
Middle East-linked energy supply shocks put Asean Power Grid back in focus
